Report: Pharmaceutical giant close to deal for Philadelphia's Spark Therapeutics
February 23, 2019 at 14:10 PM EST
A Swiss conglomerate may pay as much as $5 billion for the fast-growing gene therapy company, the Wall Street Journal reports.
